Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Hydroxychloroquine in covid-19: no proven efficacy, including in less severe forms of the disease

"Top Texts of 2020", from the editors of Prescrire International

Covid-19: remdesivir (Veklury°) authorised in the European Union, yet much remains unknown or uncertain

Covid-19 and severe breathing problems: dexamethasone reduced mortality in one trial

Andexanet alfa (Ondexxya°) as an antidote to xabans: inadequate clinical evaluation

In the July-August issue of Prescrire International: aflibercept (Eylea°) in diabetic macular oedema without visual impairment

Proper evaluation, for patients' sake

Pulmonary arterial hypertension: sometimes drug-induced

Prescrire's annual drug packaging review: slow progress and dangers

Illustrated examples of dangerous drug packaging, from Prescrire's annual packaging review

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90